Patient-Reported Outcomes of Bimatoprost for Eyelash Growth | Zendy

Steven Fagien | Zendy; John G. Walt | Zendy; Jean Carruthers | Zendy; Sue Ellen Cox | Zendy; David Wirta | Zendy; Emily Weng | Zendy; Frederick C. Beddingfield | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Patient-Reported Outcomes of Bimatoprost for Eyelash Growth

Author(s) -

Steven Fagien,

John G. Walt,

Jean Carruthers,

Sue Ellen Cox,

David Wirta,

Emily Weng,

Frederick C. Beddingfield

Publication year - 2013

Publication title -

aesthetic surgery journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.528

H-Index - 58

eISSN - 1527-330X

pISSN - 1090-820X

DOI - 10.1177/1090820x13495887

Subject(s) - bimatoprost , eyelash , medicine , patient satisfaction , randomized controlled trial , ophthalmology , dermatology , latanoprost , surgery , glaucoma , genetics , biology

Hypotrichosis of the eyelashes may negatively influence an individual's self-perception and appearance. Assessing the impact of treatment from a patient's perspective may be particularly relevant in trials of aesthetic agents. Once-daily dermal (topically applied) administration of bimatoprost ophthalmic solution 0.03% has been associated with increased eyelash prominence (ie, length, thickness, darkness).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research